top of page

Search Results

41 items found for ""

  • Patient Test Results | CDL

    Patient Test Results If you provided a doctor's order/referral, your results will be delivered to your physician either via fax or via their portal (if they have established an account with us). If you did not provide an order/referral, your results will be sent to you directly via email in the form of a PDF file. ​ Patients are able to request a copy of their results at any time. If you'd like to request a copy of your lab results, please contact us using the button below. Email Us About Lab Results

  • Double-Stranded DNA (DsDNA) Antibody

    Double-Stranded DNA (DsDNA) Antibody Ordering Recommendation Secondary screening for systemic lupus erythematosus (SLE) based on ANA results. Mnemonic Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Semi-Quantitative Indirect Fluorescent Antibody Performed Mon-Sat Reported 1-3 Days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Plasma. Contaminated, hemolyzed, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 month (avoid repeated freeze/thaw cycles) Reference Interval 24 IUs or less Double-Stranded DNA (dsDNA) Ab IgG ELISA Interpretive Data Positivity for anti-double stranded DNA (anti-dsDNA) IgG antibody is a diagnostic criterion of systemic lupus erythematosus (SLE). Specimens are initially screened by enzyme-linked immunosorbent assay (ELISA). If ordered as reflex (0050215), positive ELISA results (>24 IU) will be reflexed to a highly specific IFA titer (Crithidia luciliae indirect fluorescent test [CLIFT]) for confirmation. Some patients with early or inactive SLE may be positive for anti-dsDNA IgG by ELISA but negative by CLIFT. If the patient is negative by CLIFT but positive by ELISA and clinical suspicion remains, consider antinuclear antibody (ANA) testing by IFA. Note If dsDNA IgG antibody is detected, the result will be confirmed by Double-Stranded DNA (dsDNA) Antibody, IgG by IFA (using Crithidia luciliae). Additional charges apply. CPT Code 86225; if reflexed, add 86256 Components Component Chart Name Component Test Code LOINC Double-Stranded DNA (dsDNA) Ab IgG ELISA 0050215 58465-6 Aliases anti-DNA Anti-dsDNA Antibody Anti-Native DNA Antibody to ds-DNA Crithidia luciliae DNA ds Ab Double stranded DNA antibody ds DNA Ab ds-DNA ds-DNA IgG dsDNA reflex dsDNA reflex panel Native double-stranded DNA antibody

  • Comprehensive Metabolic Panel

    Comprehensive Metabolic Panel Ordering Recommendation Mnemonic Methodology Quantitative Ion-Selective Electrode/Quantitative Enzymatic Assay/Quantitative Spectrophotometry Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Protect from light. Allow serum tube to clot completely at room temperature. Separate serum or plasma from cells ASAP or within 30 minutes of collection. Transfer 1 mL serum or plasma to an Amber Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: EDTA, citrate, oxalate, or sodium fluoride/potassium oxalate. Remarks: Stability: After separation from cells: Ambient: Calcium and CO2: 4 hours, All others: 24 hours; Refrigerated: 1 week; Frozen: 2 weeksated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 19 Units or less 20-39 Units Negative Weak Positive 40-59 Units Moderate Positive 60 Units or Greater Strong Positive Interpretive Data Note Tests included in this panel: Albumin, Serum or Plasma (0020030), Alkaline Phosphatase, Serum or Plasma (0020005), Aspartate Aminotransferase, Serum or Plasma (0020007), Alanine Aminotransferase, Serum or Plasma (0020008), Bilirubin, Total, Serum or Plasma (0020032), Calcium, Serum or Plasma (0020027), Carbon Dioxide, Serum or Plasma (0020004), Creatinine, Serum or Plasma (0020025), Chloride, Serum or Plasma (0020003), Glucose, Serum or Plasma (0020024), Potassium, Plasma or Serum (0020002), Protein, Total, Plasma or Serum (0020029), Sodium, Plasma or Serum (0020001), and Urea Nitrogen, Plasma or Serum (0020023). CPT Code 80053 Components Component Chart Name Component Test Code LOINC Sodium, Serum or Plasma 0020001 2951-2 0020002 Potassium, Serum or Plasma 2823-3 0020003 0020004 Chloride, Serum or Plasma 2075-0 Carbon Dioxide, Serum or Plasma 2028-9 0020005 0020007 Alkaline Phosphatase 6768-6 Aspartate Aminotransferase 1920-8 0020008 0020023 Alanine Aminotransferase 1742-6 Urea Nitrogen, Serum or Plasma 0020024 0020025 3094-0 Glucose, Serum or Plasma Creatinine, Serum or Plasma 2345-7 2160-0 0020027 0020029 Calcium, Serum or Plasma Protein Total, Serum/Plasma 17861-6 2885-2 0020030 0020032 Albumin, Serum or Plasma Bilirubin, Total, Serum or Plasma 1751-7 1975-2 0020396 3004293 Anion Gap UH EGFR 33037-3 Aliases ​ACPA Antibody ​Anti Citrulline Anti-CCP C12 Chem 12 Chemistry Panel Chemistry Screen CMP SMA 12 SMA 20 SMAC ​ ​ ​

  • Cardiolipin Antibody, IgA

    Cardiolipin Antibody, IgA Ordering Recommendation Preferred second-line test when seronegative antiphospholipid syndrome (APS) is strongly suspected. Order incrementally or concurrently with other noncriteria antiphospholipid antibody tests. Mnemonic CARDIO IGA Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, heat-inactivated, hemolyzed, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval <=12 MPL Negative 13-19 MPL Indeterminate 20-80 MPL Low to Moderately Positive 81 MPL or above High Positive Interpretive Data The persistent presence of IgG and/or IgM cardiolipin (CL) antibodies in moderate or high levels (greater than 40 GPL and/or greater than 40 MPL units) is a laboratory criterion for the diagnosis of antiphospholipid syndrome (APS). Persistence is defined as moderate or high levels of IgG and/or IgM CL antibodies detected in two or more specimens drawn at least 12 weeks apart (J Throm Haemost. 2006;4:295-306). Lower positive levels of IgG and/or IgM CL antibodies (above cutoff but less than 40 GPL and/or less than 40 MPL units) may occur in patients with the clinical symptoms of APS; therefore, the actual significance of these levels is undefined. Results should not be used alone for diagnosis and must be interpreted in light of APS-specific clinical manifestations and/or other criteria phospholipid antibody tests. Compliance Category: FDA Note MPL = IgM phospholipid units CPT Code 86147 Components Component Chart Name Cardiolipin Antibody IgM Component Test Code 0050902 LOINC 3182-3 Aliases ACA aCL aCL Antibody aCL IgG Anti-Cardiolipin Anticardiolipin Anticardiolipin Antibodies Cardiolip

  • Lipid Panel

    Lipid Panel Ordering Recommendation Use to assess cardiovascular disease risk and guide therapy. Mnemonic Methodology Quantitative Enzymatic Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Refer to individual components. Collect: Plasma separator tube or serum separator tube. Specimen Preparation: Allow serum tube to clot completely at room temperature. Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to a standard transport tube. (Min: 0.5 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Body fluid (refer to Cholesterol, Fluid; Triglycerides, Fluid; and Chylomicron Screen, Body Fluid). Remarks: Stability: After separation from cells: Ambient: 24 hours; Refrigerated: 7 days; Frozen: 3 months Reference Interval Interpretive Data An HDL cholesterol less than 40 mg/dL is low and constitutes a coronary heart disease risk factor. An HDL cholesterol greater than 60 mg/dL is a negative risk factor for coronary heart disease. Non-HDL cholesterol is a secondary target of therapy in persons with high serum triglycerides (greater than 199 mg/dL). The goal for non-HDL cholesterol in persons with high triglycerides is 30 mg/dL higher than their LDL cholesterol goal. CHD Risk Factors +1 Men, 45 years and older +1 Women, 55 years and older or premature menopause without estrogen therapy +1 Family history of premature CHD +1 Current smoking +1 Hypertension +1 Diabetes mellitus +1 Low HDL cholesterol: 39 mg/dL or less -1 High HDL cholesterol: 60 mg/dL or greater Desirable Adult Values Higher Risk Borderline Total Cholestorol Triglycerides 199 mg/dL or less 149 mg/dL or less 200-239 mg/dL 150-199 mg/dL 240 mg/dL or greater 200-499 mg/dL HDL Cholestorol LDL Cholesterol (calculated) 40 mg/dL or greater 129 mg/dL or less (99 mg/dL or less if patient has CHD) 39 mg/dL or less 130-159 mg/dL 160 mg/dL or greater VLDL Cholesterol (calculated) 30 mg/dL or less Desirable Children & Adolescents Higher Risk Borderline Total Cholestorol 169 mg/dL or less 170-199 mg/dL Triglycerides 149 mg/dL or less 150-199 mg/dL HDL Cholestorol LDL Cholesterol (calculated) 40 mg/dL or greater 109 mg/dL or less 110-129 mg/dL VLDL Cholesterol (calculated) 30 mg/dL or less 200 mg/dL or greater 200-499 mg/dL 39 mg/dL or less 130 mg/dL or greater Note CPT Code 80061 Components Component Test Code 0020031 0020040 0020051 0020053 0020551 0020705 0020008 0020023 0020024 0020025 0020027 0020029 0020030 0020032 0020396 3004293 Component Chart Name Sodium, Serum or Plasma Potassium, Serum or Plasma Chloride, Serum or Plasma Carbon Dioxide, Serum or Plasma Alkaline Phosphatase Aspartate Aminotransferase Alanine Aminotransferase Urea Nitrogen, Serum or Plasma Glucose, Serum or Plasma Creatinine, Serum or Plasma Calcium, Serum or Plasma Protein Total, Serum/Plasma Albumin, Serum or Plasma Bilirubin, Total, Serum or Plasma Anion Gap UH EGFR LOINC 2951-2 2823-3 2075-0 2028-9 6768-6 1920-8 1742-6 3094-0 2345-7 2160-0 17861-6 2885-2 1751-7 1975-2 33037-3 Aliases ​ACPA Antibody ​Anti Citrulline Anti-CCP C12 Chem 12 Chemistry Panel Chemistry Screen CMP SMA 12 SMA 20 SMAC ​ ​ ​

  • Allergen, Food, Egg Whole

    Allergen, Food, Egg Whole Ordering Recommendation Not recommended for initial thyroid disorders testing. Distinguish thyroid autoimmune disorders from nonautoimmune disease or hypothyroidism. Mnemonic EGGWHOLE Methodology Quantitative ImmunoCAP Fluorescent Enzyme Immunoassay Performed Mon-Sat Reported 1-3 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Multiple patient encounters should be avoided. Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Grossly hemolyzed or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year Reference Interval Probability of IgE Mediated Clinical Reaction Reporting Range (reported in kU/L) Class Scoring No significant level detected Less than 0.10 0 0.10 - 0.34 0.35 - 0.70 Clinical relevance undetermined Low 0/1 1 0.71 - 3.50 3.51 - 17.50 Moderate High 2 3 17.51 - 50.00 50.01 - 100.00 Very high Very high 4 5 Greater than 100.00 Very high 6 Interpretive Data Allergen results of 0.10-0.34 kU/L are intended for specialist use as the clinical relevance is undetermined. Even though increasing ranges are reflective of increasing concentrations of allergen-specific IgE, these concentrations may not correlate with the degree of clinical response or skin testing results when challenged with a specific allergen. The correlation of allergy laboratory results with clinical history and in vivo reactivity to specific allergens is essential. A negative test may not rule out clinical allergy or even anaphylaxis. Compliance Category: FDA Note Components CPT Code 86003 Component Chart Name Allergen, Food, Egg Whole IgE Component Test Code 0055381 LOINC 7291-8 Aliases ImmunoCAP f245

  • Home | Clinical Diagnostic Laboratories

    OUR CURRENT HOURS ARE: Monday 9am - 3pm Tuesday 9am - 3pm Wednesday 9am - 3pm Thursday 9am - 3pm Friday 9am - 3pm Saturday 9am - 3pm* Sunday: Closed* *Appointments on Saturday, Sunday, and major Holidays are by appointment only Schedule An Appointment ABOUT CLINICAL DIAGNOSTIC LABORATORIES Preferred Diagnostic Center in Loudoun County Our main goal is to provide an alternative testing facility for individuals: doctors, as well as hospitals that is affordable and convenient. What makes Clinical Diagnostics Laboratories different from the others? We provide excellent service with a personal and friendly touch. We have an on-call Director at the Lab who has a Ph.D. in Pathology. Our Full-time Technologist has over ten years of experience in the Medical Lab field. Clinical Diagnostic Laboratories has grown quickly throughout the area with respect to returning individuals, referrals and walk-ins because we treat our patients with dignity and respect. “Clinical Diagnostic Laboratories is recognized as the TOP Diagnostic Lab for the Northern Virginia, Washington, DC and Maryland regions and is featured on the TOP Doctors Interviews which are seen on CNN Headline News, MSNBC, Oprah Winfrey Network, BRAVO and other networks” About Us Services We Provide Our laboratory provides services for a variety of organizations and companies across a wide array of industries. Whether you're a private organization, government contractor, medical facility, small to large company, or something else entirely, we have the resources to help you achieve your desired goals. Please inquire for more information. View All Services We Accept Most Insurances At our Medical Laboratory, we accept most forms of insurance. We strive to make our services as accessible as possible, so nearly all forms of insurance are accepted. However, we recommend that you check with your insurance provider to make sure your coverage is up-to-date. ​ Let Us Come to You Our on-site services extend to Northern Virginia, Maryland, and Washington DC We care about our patients and understand that being home-bound or taking time out of your busy schedule can make diagnostic testing inconvenient, that is why Clinical Diagnostics Laboratories will come to you. Schedule An Appointment

  • LIFE INSURERS | CDL

    Services for Life Insurance Companies We Care About Your Applicants Clinical Diagnostics Laboratories cares about your applicants and their goal to acquire life insurance. We promise to provide your life insurance applicants with professional laboratory testing to assist in their application process that is done with dignity. We provide laboratory testing using state-of-the-art testing equipment. With the ability to gain results in 24hrs with easy scheduling options . Our highly skilled professionals are on standby to treat your applicants with the highest degree of care and efficiency. Click here today to get started. Contact Us

  • Anti-Mitochondrial Antibody (AMA)

    Mitochondrial M2 Antibody, IgG (ELISA) Ordering Recommendation May be useful in confirming a diagnosis of primary biliary cholangitis. Mnemonic AMA Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma. Contaminated, hemolyzed, grossly icteric, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 20.0 Units or less Negative 20.1-24.9 Units 25.0 Units or greater Equivocal Positive Interpretive Data Anti-mitochondrial antibodies (AMA) are thought to be present in 90-95% of patients with primary biliary cholangitis (PBC). However, the frequency of detected antibodies may be cohort or assay dependent, as lower sensitivities have been reported. Not all PBC patients are positive for AMA; some patients may be positive for SP100 and/or GP210 antibodies. A negative result does not rule out PBC. Compliance Category: FDA Note CPT Code 86381 Components Component Chart Name Mitochondrial (M2) Antibody, IgG Component Test Code 0050065 LOINC 14251-3 Aliases AMA ANTI-MITOCHONDIRAL ANTIBODY ANTIBODIES TO MICROTUBULE ASSOCIATED PROTEIN 2 ANTIMITOCHONDRIAL ANTIBODIES IMMUNOLOGY PROFILE (AMA) MITOCHONDRIAL ANTIBODIES, SERUM

  • Companies & Organizations | CDL

    We Provide Services for a Wide Variety of Companies and Organizations At our Medical Laboratory, we offer comprehensive services for companies and organizations. We provide a wide variety of medical testing, including drug screening for new employees, blood tests, and COVID or FLU testing for travel purposes. Our highly experienced team is capable of accommodating large groups efficiently and effectively. Contact us today for more information ​ Contact Us Learn More Learn More Learn More Services for Life Insurance Companies Learn More Services for Government Agencies Learn More Services for Employer Solutions Learn More

bottom of page